论文部分内容阅读
支气管哮喘是一种变态反应性疾病,是一种由多种细胞因子参与的慢性炎症性疾病,这种慢性炎症导致气道高反应性,从而产生反复发作的喘息、胸闷、呼吸困难、咳嗽等症状,严重时可呈端坐位呼吸困难,即哮喘持续状态,可危及患者生命。它是呼吸系统疾病中一种常见病多发病,严重地影响患者的工作和生活。为了更好更快的诊断和治疗该疾病,减轻患者疾苦,我们检测了支气管哮喘患者血清中lFN-γ和IL-4含量水平,以探讨两者在该疾病发生发展中的作用及其临床意义。
Bronchial asthma is an allergic disease that is a chronic inflammatory disease involving a variety of cytokines that leads to airway hyperresponsiveness that can result in recurrent wheezing, chest tightness, breathing problems, coughing, and the like Symptoms, severe end-to-end breathing difficulties, that is, the continued state of asthma, can endanger the lives of patients. It is a common disease in respiratory diseases and frequently-occurring disease, seriously affecting the patient’s work and life. In order to diagnose and treat the disease better and reduce the suffering of patients, we examined the serum levels of lFN-γ and IL-4 in patients with bronchial asthma to explore the role of both in the occurrence and development of the disease and its clinical significance .